HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023
Abstract
Authors
M Mooghali A Mohammad JD Wallach AP Mitchell JS Ross R Ramachandran